Literature DB >> 12761765

Activities of prenylphenol derivatives from fruitbodies of Albatrellus spp. on the human and rat vanilloid receptor 1 (VR1) and characterisation of the novel natural product, confluentin.

Veronika Hellwig1, Reilinde Nopper, Frank Mauler, Joachim Freitag, Liu Ji-Kai, Ding Zhi-Hui, Marc Stadler.   

Abstract

Several prenylphenols from basidiocarps of European and Chinese Albatrellus spp., namely grifolin (1), neogrifolin (2), confluentin (3), scutigeral (4), and albaconol (5) were investigated concerning their activities in test models for vanilloid receptor modulation. The isolation of these compounds from A. confluens and structure elucidation of the novel natural product confluentin (3) are described. The effects of scutigeral and neogrifolin on vanilloid receptors were studied by means of electrophysiological methodology on rat dorsal root ganglion neurons as well as on recombinant cell lines expressing the rat VR1 receptor. Concurrently, the effects of compounds 1-5 on a reporter cell line expressing the human vanilloid receptor VR1 were measured. In contrast to previous studies reported in the literature, the results of these investigations suggest that fungal prenylphenols act as weak antagonists (activity in the microM range), rather than exhibiting agonistic activities.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12761765     DOI: 10.1002/ardp.200390008

Source DB:  PubMed          Journal:  Arch Pharm (Weinheim)        ISSN: 0365-6233            Impact factor:   3.751


  9 in total

1.  Apoptosis prediction via inhibition of AKT signaling pathway by neogrifolin.

Authors:  Yang Chen; Guo-Fang Peng; Xiang-Zhen Han; Wei Wang; Guo-Qiang Zhang; Xiao Li
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

2.  Albatrellus confluens (Alb. & Schwein.) Kotl. & Pouz.: Natural Fungal Compounds and Synthetic Derivatives with In Vitro Anthelmintic Activities and Antiproliferative Effects against Two Human Cancer Cell Lines.

Authors:  Mthandazo Dube; Dayma Llanes; Mohamad Saoud; Robert Rennert; Peter Imming; Cécile Häberli; Jennifer Keiser; Norbert Arnold
Journal:  Molecules       Date:  2022-05-05       Impact factor: 4.927

Review 3.  Targeting the signaling in Epstein-Barr virus-associated diseases: mechanism, regulation, and clinical study.

Authors:  Ya Cao; Longlong Xie; Feng Shi; Min Tang; Yueshuo Li; Jianmin Hu; Lin Zhao; Luqing Zhao; Xinfang Yu; Xiangjian Luo; Weihua Liao; Ann M Bode
Journal:  Signal Transduct Target Ther       Date:  2021-01-12

4.  ThermoTRP channels in nociceptors: taking a lead from capsaicin receptor TRPV1.

Authors:  Sravan Mandadi; Basil D Roufogalis
Journal:  Curr Neuropharmacol       Date:  2008-03       Impact factor: 7.363

Review 5.  Harnessing ortho-Quinone Methides in Natural Product Biosynthesis and Biocatalysis.

Authors:  Trevor N Purdy; Bradley S Moore; April L Lukowski
Journal:  J Nat Prod       Date:  2022-02-02       Impact factor: 4.803

6.  Neoalbaconol induces energy depletion and multiple cell death in cancer cells by targeting PDK1-PI3-K/Akt signaling pathway.

Authors:  Q Deng; X Yu; L Xiao; Z Hu; X Luo; Y Tao; L Yang; X Liu; H Chen; Z Ding; T Feng; Y Tang; X Weng; J Gao; W Yi; A M Bode; Z Dong; J Liu; Y Cao
Journal:  Cell Death Dis       Date:  2013-09-19       Impact factor: 8.469

7.  Nine new farnesylphenols from the basidiomycete albatrellus caeruleoporus.

Authors:  Liang-Yan Liu; Zheng-Hui Li; Gang-Qiang Wang; Kun Wei; Ze-Jun Dong; Tao Feng; Gen-Tao Li; Yan Li; Ji-Kai Liu
Journal:  Nat Prod Bioprospect       Date:  2014-04-23

8.  Grifolin, neogrifolin and confluentin from the terricolous polypore Albatrellus flettii suppress KRAS expression in human colon cancer cells.

Authors:  Almas Yaqoob; Wai Ming Li; Victor Liu; Chuyi Wang; Sebastian Mackedenski; Linda E Tackaberry; Hugues B Massicotte; Keith N Egger; Kerry Reimer; Chow H Lee
Journal:  PLoS One       Date:  2020-05-05       Impact factor: 3.240

9.  Herbal compounds and toxins modulating TRP channels.

Authors:  Joris Vriens; Bernd Nilius; Rudi Vennekens
Journal:  Curr Neuropharmacol       Date:  2008-03       Impact factor: 7.363

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.